SFX by Ex Libris Inc.

Title:	Functional genomic screen for modulators of ciliogenesis and cilium length
Source:	Nature [0028-0836] Kim, J yr:2010

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Thoma, Claudio R. "pVHL and GSK3Î² are components of a primary cilium-maintenance signalling network." Nature Cell Biology 9.5 (2007): 588-595.
description	2.	Cichowski, K. "Drug discovery: inhibitors that activate." Nature 464.7287 (2010): 358-359.
description	3.	West, Stephen R R. "p19ARF directly and differentially controls the functions of c-Myc independently of p53." Nature 431.7009 (2004): 712-7.
description	4.	Guo, Y. "Functional genomic screen reveals genes involved in lipid-droplet formation and utilization." Nature 453.7195 (2008): 657-661.
description	5.	Ou, G. "Sensory Ciliogenesis in Caenorhabditis elegans: Assignment of IFT components into Distinct Modules Based on Transport and Phenotypic Profiles." Molecular biology of the cell 18.5 (2007): 1554-1569.
description	6.	Poulikakos, Poulikos I. "RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF." Nature 464.7287 (2010): 427-430.
description	7.	Marie, M. "Membrane traffic in the secretory pathway : Take the 'A' train: on fast tracks to the cell surface." Cellular and molecular life sciences 65.18 (2008): 2859-74.
description	8.	Yang, L. "lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs." Nature 500.7464 (2013): 598-602.
description	9.	Solit, D. "Drug discovery: How melanomas bypass new therapy." Nature 468.7326 (2010): 902-903.
description	10.	Windecker, S. "Bub1 and Bub3 promote the conversion from monopolar to bipolar chromosome attachment independently of shugoshin." EMBO Reports 10.9 (2009): 1022-8.
description	11.	Weisberg, E. "Discovery of a small molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFR{alpha}, Kit, and Src kinases." Blood (2010).
description	12.	Quirk, Gregory J. "Neuroscience: Editing out fear." Nature 463.7277 (2010): 36-37.
description	13.	Lomazzi, M. "Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry." Nature genetics 31.2 (2002): 190-4.
description	14.	Linggi, B. "The t(8;21) fusion protein, AML1-ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia." Nature Medicine 8.7 (2002): 743-750.
description	15.	DeMorin, F. "Selective Inhibitors of the Mutant B-Raf Pathway: Discovery of a Potent and Orally Bioavailable Aminoisoquinoline." Journal of medicinal chemistry 52.20 (2009): 6189-6192.
description	16.	Pelengaris, S. "c-MYC: more than just a matter of life and death." Nature reviews. Cancer 2.10 (2002): 764-76.
description	17.	Siddiqui, A. "Diagnosis of Strongyloides stercoralis infection." Clinical infectious diseases 33.7 (2001): 1040-1047.
description	18.	Cermelli, S. "The lipid-droplet proteome reveals that droplets are a protein-storage depot." Current biology 16.18 (2006): 1783-1795.
description	19.	FitzGerald, M J J. "Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc." Oncogene 18.15 (1999): 2489-98.
description	20.	Li, M. "Electrospinning polyaniline-contained gelatin nanofibers for tissue engineering applications." Biomaterials 27.13 (2006): 2705-2715.